Phase 3 Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing to take part voluntarily, sign a consent form, and are able to follow the study procedures
• People aged 18 to 75 years old at the time of enrolment, of any gender
• People whose lung cancer has been confirmed by a tissue or cell sample test to be a specific type (non-squamous, non-small cell lung cancer) that has spread to other parts of the body (stage IV), as classified by a standard medical staging system
• People whose cancer does not have certain specific genetic changes known as EGFR sensitive mutations or ALK gene translocations
• People whose doctors expect them to survive for at least 3 months
• People who are largely able to care for themselves and carry out daily activities, as measured by a standard medical scoring tool (a score of 0 or 1 on the ECOG scale)

Who may not be able to join:

• People who have had radiation therapy to the lungs at a dose above 30 Gy within the 6 months before starting the trial
• People who have completed palliative radiation therapy within 7 days before starting the trial
• People who are expected to need any other type of cancer treatment during the study period
• People who have fluid around the heart, lungs, or in the abdomen that is uncontrolled or causing symptoms and requires repeated draining
• People who have cancer that has spread to the brain stem, the lining of the brain and spinal cord, or the spinal cord itself, or who have spinal cord compression

Important: Always verify eligibility with the trial site directly before applying.